Pacific Biosciences of California Ownership | Who Owns Pacific Biosciences of California?


OverviewForecastRevenueFinancialsChartTranscripts

Pacific Biosciences of California Ownership Summary


Pacific Biosciences of California is owned by 84.91% institutional investors, 1.85% insiders, and 13.24% retail investors. Ark investment management is the largest institutional shareholder, holding 12.32% of PACB shares. ARK Innovation ETF is the top mutual fund, with 7.15% of its assets in Pacific Biosciences of California shares.

PACB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPacific Biosciences of California84.91%1.85%13.24%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryMedical Device Stocks53.39%8.20%38.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ark investment management33.21M12.32%$45.50M
Vanguard group26.00M9.64%$35.62M
Blackrock23.61M8.76%$32.34M
Madrone advisors23.39M8.68%$32.05M
Edmond de rothschild16.74M6.21%$22.93M
Nikko asset management americas12.64M4.69%$17.19M
Sumitomo mitsui trust12.64M4.69%$17.32M
Bank of new york mellon9.94M3.69%$13.61M
Jackson square partners8.88M3.30%$12.17M
Geode capital management6.10M2.26%$8.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Madrone advisors23.39M5.63%$32.05M
Vk services2.63M0.88%$3.61M
Jackson square partners8.88M0.74%$12.17M
Oracle investment management423.14K0.54%$579.70K
Bourne lent asset management951.39K0.50%$1.30M
Ark investment management33.21M0.40%$45.50M
Edmond de rothschild16.74M0.39%$22.93M
Nikko asset management americas12.64M0.20%$17.19M
Koa wealth management120.00K0.14%$164.40K
Casdin capital1.04M0.11%$1.42M

Top Buyers

HolderShares% AssetsChange
Edmond de rothschild16.74M0.39%6.23M
Madrone advisors23.39M5.63%5.80M
Goldman sachs group3.98M0.00%1.78M
Jackson square partners8.88M0.74%1.70M
Assenagon asset management1.30M0.00%1.30M

Top Sellers

HolderShares% AssetsChange
T. rowe price investment management---8.40M
Deep track capital, lp---7.00M
Macquarie group---6.64M
Bellevue group---4.59M
Farallon capital management135.00K0.00%-3.64M

New Positions

HolderShares% AssetsChangeValue
Norges bank1.21M0.00%1.21M$1.66M
Mirae asset global etfs818.90K0.00%818.90K$1.12M
Squarepoint ops524.61K0.00%524.61K$718.71K
Federated hermes446.85K0.00%446.85K$612.19K
Corebridge financial147.16K0.00%147.16K$201.61K

Sold Out

HolderChange
Sjs investment consulting-6.00
Dinuzzo private wealth-7.00
Financial gravity asset management-13.00
Jfs wealth advisors-14.00
Nelson, van denburg & campbell wealth management group-51.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024232-3.33%231,728,472-4.37%841.05%88-24.79%7631.03%
Jun 30, 2024240-14.29%242,326,497-8.40%890.93%117-15.83%58-17.14%
Mar 31, 2024280-2.78%264,539,978-5.82%980.80%139-10.32%70-6.67%
Dec 31, 20232880.35%280,890,6427.39%1101.05%15513.97%75-13.79%
Sep 30, 20232871.41%261,557,2113.11%1020.99%136-6.21%8731.82%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Innovation ETF21.05M7.15%206.78K
ARK Disruptive Innovation Full Composite18.86M6.92%1.17K
ARK Genomic Revolution12.54M4.60%269.15K
EdRF Big Data N EUR13.27M4.51%1.01M
ARK Genomic Revolution ETF12.74M4.33%253.89K
Vanguard Total Stock Mkt Idx Inv8.93M3.26%-
iShares Russell 2000 ETF7.58M2.58%-15.85K
Nikko AM ARK Pstv Chg Innovt P JPY Acc6.01M2.04%-669.62K
Vanguard Institutional Extnd Mkt Idx Tr3.91M1.43%-12.74K
Nikko AM ARK Disruptive Innovation A USD4.18M1.42%-289.78K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 30, 2024Kim Susan G. See RemarksSell$34.06K
Sep 16, 2024HENRY CHRISTIAN O See RemarksSell$172.69K
Aug 19, 2024Eidel Jeff See RemarksSell$42.60K
Aug 16, 2024Van Oene Mark See RemarksSell$63.17K
May 20, 2024Farmer Michele See RemarksSell$10.71K

Insider Transactions Trends


DateBuySell
2024 Q3-4
2024 Q2-1
2024 Q1112
2023 Q4-1
2023 Q3-6

PACB Ownership FAQ


Who Owns Pacific Biosciences of California?

Pacific Biosciences of California shareholders are primarily institutional investors at 84.91%, followed by 1.85% insiders and 13.24% retail investors. The average institutional ownership in Pacific Biosciences of California's industry, Medical Device Stocks, is 53.39%, which Pacific Biosciences of California exceeds.

Who owns the most shares of Pacific Biosciences of California?

Pacific Biosciences of California’s largest shareholders are Ark investment management (33.21M shares, 12.32%), Vanguard group (26M shares, 9.64%), and Blackrock (23.61M shares, 8.76%). Together, they hold 30.72% of Pacific Biosciences of California’s total shares outstanding.

Does Blackrock own Pacific Biosciences of California?

Yes, BlackRock owns 8.76% of Pacific Biosciences of California, totaling 23.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.34M$. In the last quarter, BlackRock increased its holdings by 213.7K shares, a 0.91% change.

Who is Pacific Biosciences of California’s biggest shareholder by percentage of total assets invested?

Madrone advisors is Pacific Biosciences of California’s biggest shareholder by percentage of total assets invested, with 5.63% of its assets in 23.39M Pacific Biosciences of California shares, valued at 32.05M$.

Who is the top mutual fund holder of Pacific Biosciences of California shares?

ARK Innovation ETF is the top mutual fund holder of Pacific Biosciences of California shares, with 7.15% of its total shares outstanding invested in 21.05M Pacific Biosciences of California shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools